BEONE MEDICINES LTD. — Investor Relations & Filings
About BEONE MEDICINES LTD.
BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2024年度持续督导跟踪报告 | 2025-05-09 | Chinese | |
| 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司首次公开发行股票并上市之持续督导保荐总结报告书 | 2025-05-09 | Chinese | |
| 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2024年持续督导工作现场检查报告 | 2025-05-09 | Chinese | |
| 港股公告：证券变动月报表 | 2025-05-09 | Chinese | |
| 美股公告：季度报告10-Q表格 | 2025-05-07 | Chinese | |
| 港股公告：百济神州有限公司截至2025年3月31日止三个月未经审核业绩以及业务进展最新情况 | 2025-05-07 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 38978496 | 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2024年度持续督导跟踪报告 | 2025-05-09 | Chinese | ||
| 38978481 | 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司首次公开发行股票并上市之持续督导保荐总结报告书 | 2025-05-09 | Chinese | ||
| 38978466 | 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2024年持续督导工作现场检查报告 | 2025-05-09 | Chinese | ||
| 38978457 | 港股公告：证券变动月报表 | 2025-05-09 | Chinese | ||
| 38978445 | 美股公告：季度报告10-Q表格 | 2025-05-07 | Chinese | ||
| 38978413 | 港股公告：百济神州有限公司截至2025年3月31日止三个月未经审核业绩以及业务进展最新情况 | 2025-05-07 | Chinese | ||
| 38978403 | 百济神州有限公司2025年第一季度主要财务数据公告 | 2025-05-07 | Chinese | ||
| 38978395 | 美股公告：表格F-6/A | 2025-05-05 | Chinese | ||
| 38978355 | 港股公告：翌日披露报表 | 2025-05-05 | Chinese | ||
| 38978345 | 港股公告：翌日披露报表 | 2025-04-30 | Chinese | ||
| 38978338 | 百济神州有限公司关于公司涉及诉讼的进展公告 | 2025-04-30 | Chinese | ||
| 38978330 | 港股公告：翌日披露报表 | 2025-04-29 | Chinese | ||
| 38978327 | 上海市方达律师事务所关于百济神州有限公司（BeiGene, Ltd.）2025年第一次临时股东大会（股东特别大会）的法律意见书 | 2025-04-29 | Chinese | ||
| 38978321 | 百济神州有限公司2025年第一次临时股东大会（股东特别大会）决议公告 | 2025-04-29 | Chinese | ||
| 38978317 | 中国国际金融股份有限公司、高盛（中国）证券有限责任公司关于百济神州有限公司2024年度募集资金存放与使用情况的核查意见 | 2025-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BEONE MEDICINES LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58263/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58263 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58263 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58263 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58263}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BEONE MEDICINES LTD. (id: 58263)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.